Top Markets
#1 Official Trump Official Trump +52.13%
#2 Melania Meme Melania Meme +30.96%
#3 Mubarak Mubarak +26.81%
#4 EXOD EXOD +18.93%
#5 Movement Movement +18.38%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +17.15%
#7 POL (ex-MATIC) POL (ex-MATIC) +13.17%
#8 Decred Decred +12.61%
#9 Wrapped POL Wrapped POL +11.74%
#10 Nockchain Nockchain +11.72%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Vaxcell-Bio Therapeutics Co., Ltd. Vaxcell-Bio Therapeutics Co., Ltd.

Vaxcell-Bio Therapeutics Co., Ltd.

323990
Rank in Stocks #24157
Established in 2010, Vaxcell-Bio Therapeutics Co., Ltd. specializes in the... Established in 2010, Vaxcell-Bio Therapeutics Co., Ltd. specializes in the research, development, and commercialization of immune cell-based therapies designed to treat cancer, primarily operating within South Korea. The company's main base of operations is located in Hwasun-eup, South Korea.
Share Price
$2.77
Last synced: 2026-08-21
Market Cap
$64.26M
Change (1 day)
-4.64%
Change (1 year)
-57.45%
Country
KR
Trade Vaxcell-Bio Therapeutics Co., Ltd. (323990)

Category

Healthcare
Revenue for Vaxcell-Bio Therapeutics Co., Ltd. (323990)
Revenue in Aug 2026 TTM: 0
According to Vaxcell-Bio Therapeutics Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Vaxcell-Bio Therapeutics Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH